Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
09969
09969 News & Events
-
Add to Watchlist
Trade 09969
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
09969 News
INNOCARE Anticipates First-Time NP of RMB633M Last Year, with Total Operating Revenue Projected to Increase by 134%
Jan 29 2026
aastocks
InnoCare Pharma Receives IND Approval for Phase II Trial of ICP-488 in CLE
Dec 23 2025
Globenewswire
InnoCare Pharma Receives IND Approval for Phase II Trial of ICP-488 for CLE Treatment
Dec 23 2025
Yahoo Finance
Zenas Acquires Global Rights for Orelabrutinib, Enhancing Multiple Sclerosis Treatment Potential
Dec 15 2025
Globenewswire
Zenas Acquires Global Rights for Orelabrutinib, Enhancing Multiple Sclerosis Treatment Potential
Dec 15 2025
Newsfilter
InnoCare's Orelabrutinib Phase IIb Trial Achieves Primary Endpoint in SLE Patients
Dec 14 2025
Globenewswire
InnoCare Pharma's TRK Inhibitor zurletrectinib Approved, Demonstrating High Efficacy
Dec 11 2025
Globenewswire
InnoCare Presents Orelabrutinib Study Results with 89.5% ORR at ASH 2025
Dec 10 2025
Globenewswire
Show More News
09969 Events
No data
09969 Monitor News
No data
09969 Earnings Analysis
No Data
People Also Watch
